GEM

Indian Army GILTERITINIB 40 MG TAB Procurement 2025 – IS 550/ISO standards Not Specified by DMA

Bid Publish Date

27-Oct-2025, 4:19 pm

Bid End Date

06-Nov-2025, 5:00 pm

Bid Opening Date

06-Nov-2025, 5:30 pm

Location

WEST DELHI , DELHI

Progress

Issue27-Oct-2025, 4:19 pm
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

360

Bid Type

Two Packet Bid

Key Highlights

  • • Brand/OEM requirements: Not specified in data; watch ATC document for any brand constraints
  • • Technical standards: No explicit standards listed; expect IS/ISO GMP and drug safety compliance post-spec release
  • • Special clauses: 50% quantity variation right; variable delivery timelines with minimum 30 days
  • • Eligibility criteria: Not specified; anticipate standard pharmaceutical supplier eligibility and regulatory approvals
  • • Warranty/AMC: Not mentioned in data; confirm post-tender support terms in ATC
  • • Penalty/Performance: No LD details disclosed; verify in ATC/contract terms
  • • Delivery/Installation: Quantity-based delivery with extended windows; monitor for final delivery schedule
  • • Critical requirements: Review uploaded ATC to confirm any mandatory certifications or approvals

Tender Overview

Organization: Indian Army (Department Of Military Affairs). Product: GILTERITINIB 40 MG TAB. Location: India (national level procurement). Estimated Value: Not disclosed. EMD: Not disclosed. Scope: No BOQ items available; no explicit quantity or delivery schedule shown. Notable clause permits a 50% quantity fluctuation and extension of delivery periods at contracted rates. Tender context appears to be pharmaceutical procurement under generic government tender processes. Unique aspect: reliance on standard option clause to manage demand variability. bidders should prepare for fluid quantities and adaptable delivery, with ATC documentation referenced in the uploaded file.

Technical Specifications & Requirements

  • No technical specifications provided in the tender data.
  • No BOQ items specified; no unit quantities or dosage form details beyond the generic product name.
  • ATC document linked; potential requirement to comply with government procurement standards and quality assurances once specifications are published.
  • Expected compliance considerations may include GMP, drug safety certification, and regulatory approvals, though none are explicitly listed in the current data.
  • Important implication: bidders must anticipate post-bid specification release and align with standard pharma procurement practices.

Terms, Conditions & Eligibility

  • Quantity Variability: Purchaser may increase/decrease quantity up to 50% of bid/contract quantity.
  • Delivery Window: Additional delivery time calculated as (Additional quantity ÷ Original quantity) × Original delivery period, minimum 30 days.
  • Delivery Period: Extended delivery possible within original delivery framework.
  • ATC Documentation: An ATC document has been uploaded; bidders should review for any precise compliance clauses.
  • Compliance: Bidders must adhere to generic government procurement terms and price protections as applicable.

Key Specifications

    • Product/service: GILTERITINIB 40 MG TAB
    • Quantity/Scope: Not specified in current data; expect post-release BOQ
    • EMD/Estimated value: Not disclosed; review tender documents upon release
    • Category: Pharmaceutical procurement via government tender
    • Compliance: Await IS/ISO pharma standards and GMP alignment in final specs

Terms & Conditions

  • Key Term 1: 50% quantity variation allowed by purchaser

  • Key Term 2: Delivery period adjusts with additional quantity; minimum 30 days

  • Key Term 3: Review ATC document for bidder obligations and compliance

Important Clauses

Payment Terms

Not disclosed in current data; verify in ATC/contract documents

Delivery Schedule

Delivery periods can extend based on quantity variation; minimum 30 days for added time

Penalties/Liquidated Damages

No LD details provided; confirm in final contract terms

Bidder Eligibility

  • Experience in supplying pharmaceutical products to government bodies

  • Compliance with drug procurement regulations and GMP standards

  • Financial statements demonstrating solvency and turnover adequacy

🤖 AI-Powered Bidder Prediction

Discover companies most likely to bid on this tender

Live AI
Historical Data

Required Documents

1

GST registration certificate

2

PAN card

3

Experience certificates for similar pharmaceutical supply

4

Financial statements / turnover proof

5

EMD deposit proof (amount disclosed in final tender)

6

Technical bid documents and compliance certificates (as per ATC)

7

OEM authorization (if required by final specifications)

8

Any regulatory approvals for drug procurement (if applicable)

Frequently Asked Questions

How to bid for the Indian Army pharma tender with 50% quantity variation?

Bidders should submit regulatory, financial, and GMP-compliant documents; be prepared to accommodate a 50% change in quantity at contracted rates. Review ATC terms for any binding conditions, ensure GST, PAN, and experience proofs, and confirm delivery capabilities for variable orders under the DMA procurement framework.

What documents are required for the GILTERITINIB bid in India?

Prepare GST certificate, PAN card, experience certificates of similar drug supply, financial statements, EMD proof, technical compliance documents, and OEM authorizations if applicable. Ensure ATC document review for any additional bid submission requirements specific to this tender.

What are the delivery and payment terms for the army drug tender?

Delivery terms hinge on the original delivery period with possible extension; additional time is calculated with a minimum of 30 days. Payment terms are not disclosed in the current data; bidder must confirm terms in the final contract or ATC.

What standards and certifications are required for this pharma procurement?

Final specs are not listed; anticipate GMP/ISO compliance and regulatory approvals. Bidders should await the ATC for exact standards and ensure IS/ISO certifications and drug safety compliance as per government procurement norms.

How will quantity adjustments impact the bid submission?

Bid submissions must accommodate potential increases up to 50% of contracted quantity. Prepare pricing that remains valid under fluctuations and ensure supply chain resilience for additional volumes within contracted rates.

When can bidders expect the BOQ and exact drug specifications?

BOQ and detailed specifications are not available in the current tender data. Applicants should monitor the official portal for the uploaded ATC and subsequent amendment notifications to align pricing and technical bids with final requirements.